Vascular Grafts Market By Type (Endovascular Stent Grafts, Peripheral Vascular Grafts, Hemodialysis Access Grafts, Coronary Artery By-Pass Grafts), By Material (Synthetic, Biological, Biosynthetic), By Application (Cardiovascular Diseases, Aneurysm, Kidney Failure, Vascular Occlusion) - Growth, Share, Opportunities & Competitive Analysis, 2017 - 2025

The purpose of this research study titled ‘Vascular Grafts Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide investors, developers, company executives and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global vascular grafts market. This report presents and analyzes the major trends prevalent in the global vascular grafts market and the market size and forecast.

This report categorizes the global vascular grafts market in terms of type, material, application and geographical distribution. Based on product type, the global vascular grafts market is categorized into endovascular stent grafts, peripheral vascular grafts, hemodialysis access grafts, and coronary artery by-pass graft. Synthetic (polytetrafluethylene (PTFE), polyurethane (PU), dacron, and others), biological (saphenous vein, bovine vein and others) and biosynthetic are the various vascular grafts materials studied in this report. In terms of application areas, vascular grafts find wide usage in treatment for cardiovascular diseases, aneurysm, kidney failure, vascular occlusion and diabetes. Market size and forecast for each mentioned segment for the period 2015-2025 is presented in the report along with respective CAGRs for the forecast duration 2017-2025.

Geographically, the global vascular grafts market is best understood by segmenting the market into five major regions and chief region level markets as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Rest of Middle East and Africa

The market size and forecast of each considered geographical market is presented for the period 2015-2025 along with CAGRs for the forecast period 2017-2025 in this study and are further cross-sectional presented in terms of type, material, applications and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global vascular grafts market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the vascular grafts market. The key players profiled in this report are Artegraft, Inc., B. Braun Melsungen AG, Cook Medical, Inc., C.R. Bard, Inc., CryoLife, Inc., Heart Medical Europe BV, Japan Lifeline Co., Ltd. (Junken Medical Co., Ltd), LeMaitre Vascular, Inc., MAQUET Holding B.V. & Co. KG, Medtronic plc, Shanghai Suokang Medical Implants Co. Ltd., Terumo Medical Corporation, Vascular Grafts Solutions Ltd., Vascutek Ltd. and W. L. Gore & Associates, Inc.

The global vascular grafts market is studied for the following application areas:

  • Cardiovascular Diseases
  • Aneurysm
  • Kidney Failure
  • Vascular Occlusion
  • Diabetes

Vascular Grafts Market

In 2016, cardiovascular diseases accounted for over 20% of the global vascular grafts market on account of growing prevalence of hypertension, and other age-related cardiovascular diseases, with the highest prevalence of coronary artery diseases. Cardiovascular diseases are often associated with blockage or narrowing of blood vessels and reduced blood flow. It is predicted that the by 2032, CVD mortality will cross 23 Mn mark. Vascular surgery is often recommended for treatment of CVDs when pharmaceutical administration, and dietary and lifestyle modifications prove inadequate. Vascular grafts may be used to bypass or replace damaged vessel. At present, most favored conduits for cardiovascular grafting are autologous arteries or veins, saphenous vein being the most common autograft option. Despite being the gold standard for grafting, saphenous vein grafting presents limited patency. Additionally, synthetic vascular grafts though available as an alternative to autologous grafts are used less due to poor patency rates.

Geographically, the global vascular grafts market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Vascular Grafts Market

North America is the largest regional market for vascular grafts and will continue to dominate the global market. High prevalence of chronic diseases such as diabetes, cardiovascular diseases and end-stage renal diseases and the corresponding growth in demand for surgical treatments largely contribute to the domination of North America market. Existence of developed healthcare system, favorable reimbursements and greater awareness about treatment and management of chronic diseases are major features of North America market. Additionally, Asia Pacific is anticipated to be the fastest processing market for vascular grafts during the forecast period. Rapid evolution of healthcare systems and growing penetration of major market players in the light of increasing healthcare expenditure greatly attribute to the movement of Asia Pacific market.

The detailed regional classification of the global vascular grafts market is as follows:

  • North America (U.S. & Canada)
  • Europe (Germany, U.K., France and Rest of Europe)
  • Asia Pacific (China, India, Japan and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and Rest of Latin America)
  • Middle East and Africa (GCC and Rest of Middle East and Africa)

The global vascular grafts market is studied for the following material types:

  • Synthetic    
    • Polytetrafluethylene (PTFE)
    • Polyurethane (PU)
    • Dacron
    • Others
  • Biological    
    • Saphenous Vein
    • Bovine Vein
    • Others
  • Biosynthetic

Vascular Grafts Market

At present synthetic grafts are observed to be the most preferred type worldwide. Polytetrafluethylene, Polyurethane, Dacron, etc. are highly preferred in a majority of grafting procedures. Easy availability, lesser cost, higher tensile strength are some of the factors attributing to larger market share of synthetic materials. However, biological materials have higher demand in cardiovascular treatments and are expected to be the fastest growing segment. Growing awareness about benefits of biological grafts in terms of acceptance, biocompatibility and technological advancement are the key factors contributing to the emergence of biological materials. At present internal thoracic artery and saphenous vein are the gold standard grafts used for cardiovascular procedures are outperform synthetic alternatives. However, limited availability of these grafts challenge their widespread use. To address this challenge, tissue-engineered vascular grafts (TEVG) are being rigorously explored. TEVG have offered benefits such as ability to remodel, grow and repair in-vivo without needing autograft surgery.

Choose License Type
Published Date:  Jul 2017
Category:  Medical Devices
Report ID:   58546
Report Format:   PDF
Pages:   120
Rating:    4.5 (50)
Connect With Us
+1-408-641-3282
24/7 Research Support